| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |